Altre lingue Genscript Biotech Corporation

Azioni

1548

KYG3825B1059

Tempo differito Hong Kong S.E. Altri mercati azionari 09:04:22 04/07/2024			Variaz. 5gg	Var. 1 gen.
8,84 ^HKD	-0,11%		+4,74%	-55,49%

01:09	Lo studio di fase 3 del farmaco per il mieloma multiplo di Genscript Biotech dà risultati positivi	MT
28/06	Le unità di Genscript Biotech ricevono un pagamento di 30 milioni di dollari come pietra miliare	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Genscript Biotech's Phase 3 Multiple Myeloma Drug Trial Yields Positive Results	01:09
Genscript Biotech Units Receive Milestone Payment of $30 Million	28/06
Genscript Biotech Corporation Announces Board Resignations and Changes in Composition of Board Committees	23/06
GenScript Biotech Corporation Launches FLASH Gene Service: The Most Affordable Gene Synthesis Solution on the Market	18/06
Genscript Biotech CEOs to Receive Shares Under Restricted Share Scheme	13/06
Hong Kong Stocks Rebound Following More than Expected Growth in China’s Manufacturing Sector	03/06
GenScript Biotech Draws Attention from US Congress Members; Shares Tank 18%	03/06
GenScript Biotech Shares Drop After U.S. Lawmakers Scrutinize Chinese Ties	03/06
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	01/06
US lawmakers ask FBI for briefing on GenScript Biotech's links to China	31/05
Legend Expects to Log Profit in 2026	15/05
Legend Biotech's Loss Narrows in Q1 as Revenue Surges	14/05
GenScript Biotech Corporation Announces Self-Amplifying RNA Synthesis Service for Advanced Therapeutic Applications	13/05
GenScript Biotech Releases 2023 ESG Report, Deepening Green Development Practices, Constructing Sustainable Future Blueprint	25/04
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	25/04
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint	24/04
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	24/04
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing	23/04
Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission	23/04
Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug	17/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Genscript Biotech Corporation

Azioni

1548

KYG3825B1059

Altre lingue

Filtri